Structure

Physi-Chem Properties

Molecular Weight:  498.3
Volume:  530.133
LogP:  4.664
LogD:  4.392
LogS:  -4.238
# Rotatable Bonds:  9
TPSA:  104.06
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.202
Synthetic Accessibility Score:  6.4
Fsp3:  0.667
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.668
MDCK Permeability:  1.846268969529774e-05
Pgp-inhibitor:  0.427
Pgp-substrate:  0.973
Human Intestinal Absorption (HIA):  0.051
20% Bioavailability (F20%):  0.938
30% Bioavailability (F30%):  0.08

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.225
Plasma Protein Binding (PPB):  96.01363372802734%
Volume Distribution (VD):  1.122
Pgp-substrate:  2.078763484954834%

ADMET: Metabolism

CYP1A2-inhibitor:  0.036
CYP1A2-substrate:  0.1
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.412
CYP2C9-inhibitor:  0.529
CYP2C9-substrate:  0.089
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.062
CYP3A4-inhibitor:  0.895
CYP3A4-substrate:  0.364

ADMET: Excretion

Clearance (CL):  7.424
Half-life (T1/2):  0.597

ADMET: Toxicity

hERG Blockers:  0.249
Human Hepatotoxicity (H-HT):  0.67
Drug-inuced Liver Injury (DILI):  0.947
AMES Toxicity:  0.098
Rat Oral Acute Toxicity:  0.986
Maximum Recommended Daily Dose:  0.997
Skin Sensitization:  0.762
Carcinogencity:  0.093
Eye Corrosion:  0.088
Eye Irritation:  0.051
Respiratory Toxicity:  0.979

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC138756

Natural Product ID:  NPC138756
Common Name*:   Fasciculol H
IUPAC Name:   (2R,3R,5R,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-2,3-dihydroxy-4,4,10,13,14-pentamethyl-1,2,3,5,6,7,11,15,16,17-decahydrocyclopenta[a]phenanthren-12-one
Synonyms:  
Standard InCHIKey:  DHYNMMKCYKLJKR-LDKSJVRISA-N
Standard InCHI:  InChI=1S/C30H50O5/c1-17(9-12-23(32)27(4,5)35)18-13-14-29(7)19-10-11-22-26(2,3)25(34)21(31)16-28(22,6)20(19)15-24(33)30(18,29)8/h17-18,21-23,25,31-32,34-35H,9-16H2,1-8H3/t17-,18-,21-,22+,23-,25+,28-,29+,30+/m1/s1
SMILES:  C[C@@H]([C@H]1CC[C@@]2([C@]1(C)C(=O)CC1=C2CC[C@@H]2[C@]1(C)C[C@@H](O)[C@@H](C2(C)C)O)C)CC[C@H](C(O)(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2375642
PubChem CID:   72714436
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33351 naematoloma fasciculare Species Strophariaceae Eukaryota n.a. n.a. n.a. PMID[23634786]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT148 Cell Line HCT-15 Homo sapiens IC50 > 30000.0 nM PMID[556018]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 > 30000.0 nM PMID[556018]
NPT81 Cell Line A549 Homo sapiens IC50 > 30000.0 nM PMID[556018]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 = 9860.0 nM PMID[556018]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC138756 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9643 High Similarity NPC136801
0.9205 High Similarity NPC200702
0.907 High Similarity NPC32830
0.9059 High Similarity NPC99909
0.8953 High Similarity NPC44181
0.8941 High Similarity NPC72133
0.8941 High Similarity NPC89077
0.8902 High Similarity NPC22403
0.8864 High Similarity NPC189520
0.8851 High Similarity NPC77263
0.8851 High Similarity NPC250592
0.8837 High Similarity NPC469314
0.8837 High Similarity NPC241875
0.8837 High Similarity NPC469317
0.8837 High Similarity NPC90652
0.8804 High Similarity NPC316964
0.875 High Similarity NPC289213
0.875 High Similarity NPC469400
0.8736 High Similarity NPC143767
0.8736 High Similarity NPC471722
0.8736 High Similarity NPC131470
0.8736 High Similarity NPC242864
0.8736 High Similarity NPC471724
0.8736 High Similarity NPC470417
0.8721 High Similarity NPC28252
0.8721 High Similarity NPC94755
0.8721 High Similarity NPC55309
0.869 High Similarity NPC7988
0.8652 High Similarity NPC155304
0.8636 High Similarity NPC86319
0.8636 High Similarity NPC474245
0.8636 High Similarity NPC275740
0.8621 High Similarity NPC187376
0.8621 High Similarity NPC159046
0.8621 High Similarity NPC233836
0.8605 High Similarity NPC197823
0.8588 High Similarity NPC86370
0.8539 High Similarity NPC191684
0.8539 High Similarity NPC183283
0.8523 High Similarity NPC193360
0.8506 High Similarity NPC472491
0.8506 High Similarity NPC473168
0.8506 High Similarity NPC472494
0.8488 Intermediate Similarity NPC473246
0.8488 Intermediate Similarity NPC59453
0.8488 Intermediate Similarity NPC221758
0.8478 Intermediate Similarity NPC249954
0.8462 Intermediate Similarity NPC318332
0.8462 Intermediate Similarity NPC166906
0.8444 Intermediate Similarity NPC233116
0.8444 Intermediate Similarity NPC297265
0.8444 Intermediate Similarity NPC23434
0.8444 Intermediate Similarity NPC473166
0.8444 Intermediate Similarity NPC63748
0.8427 Intermediate Similarity NPC229871
0.8427 Intermediate Similarity NPC469319
0.8427 Intermediate Similarity NPC1015
0.8427 Intermediate Similarity NPC31985
0.8427 Intermediate Similarity NPC474889
0.8427 Intermediate Similarity NPC102414
0.8427 Intermediate Similarity NPC475921
0.8427 Intermediate Similarity NPC77168
0.8427 Intermediate Similarity NPC84271
0.8427 Intermediate Similarity NPC474704
0.8421 Intermediate Similarity NPC477915
0.8421 Intermediate Similarity NPC473424
0.8409 Intermediate Similarity NPC475740
0.8409 Intermediate Similarity NPC474684
0.8409 Intermediate Similarity NPC142361
0.8404 Intermediate Similarity NPC110149
0.8391 Intermediate Similarity NPC474083
0.8391 Intermediate Similarity NPC470574
0.8391 Intermediate Similarity NPC478127
0.837 Intermediate Similarity NPC473170
0.837 Intermediate Similarity NPC297199
0.837 Intermediate Similarity NPC259286
0.837 Intermediate Similarity NPC317586
0.837 Intermediate Similarity NPC255809
0.837 Intermediate Similarity NPC470016
0.8353 Intermediate Similarity NPC6707
0.8352 Intermediate Similarity NPC274046
0.8352 Intermediate Similarity NPC69454
0.8352 Intermediate Similarity NPC198074
0.8352 Intermediate Similarity NPC475255
0.8351 Intermediate Similarity NPC323834
0.8333 Intermediate Similarity NPC175628
0.8333 Intermediate Similarity NPC191892
0.8333 Intermediate Similarity NPC111585
0.8333 Intermediate Similarity NPC20388
0.8333 Intermediate Similarity NPC148414
0.8315 Intermediate Similarity NPC53911
0.8315 Intermediate Similarity NPC328539
0.8295 Intermediate Similarity NPC31564
0.8295 Intermediate Similarity NPC475022
0.8295 Intermediate Similarity NPC145879
0.8295 Intermediate Similarity NPC51014
0.8295 Intermediate Similarity NPC222613
0.8295 Intermediate Similarity NPC474778
0.8295 Intermediate Similarity NPC118648
0.8295 Intermediate Similarity NPC474732
0.8295 Intermediate Similarity NPC474733
0.828 Intermediate Similarity NPC305483
0.828 Intermediate Similarity NPC117133
0.828 Intermediate Similarity NPC95565
0.828 Intermediate Similarity NPC7124
0.828 Intermediate Similarity NPC328162
0.828 Intermediate Similarity NPC96859
0.8276 Intermediate Similarity NPC214043
0.8276 Intermediate Similarity NPC82902
0.8276 Intermediate Similarity NPC85774
0.8272 Intermediate Similarity NPC201373
0.8261 Intermediate Similarity NPC469406
0.8261 Intermediate Similarity NPC8993
0.8261 Intermediate Similarity NPC245972
0.8261 Intermediate Similarity NPC174051
0.8261 Intermediate Similarity NPC67831
0.8261 Intermediate Similarity NPC196485
0.8261 Intermediate Similarity NPC111015
0.8256 Intermediate Similarity NPC151519
0.8256 Intermediate Similarity NPC30166
0.8247 Intermediate Similarity NPC209502
0.8247 Intermediate Similarity NPC204833
0.8242 Intermediate Similarity NPC86266
0.8242 Intermediate Similarity NPC272746
0.8242 Intermediate Similarity NPC168027
0.8242 Intermediate Similarity NPC110657
0.8242 Intermediate Similarity NPC19114
0.8242 Intermediate Similarity NPC473167
0.8242 Intermediate Similarity NPC475806
0.8242 Intermediate Similarity NPC473998
0.8242 Intermediate Similarity NPC26888
0.8242 Intermediate Similarity NPC107690
0.8242 Intermediate Similarity NPC185936
0.8242 Intermediate Similarity NPC212301
0.8242 Intermediate Similarity NPC262870
0.8235 Intermediate Similarity NPC236112
0.8222 Intermediate Similarity NPC309603
0.8222 Intermediate Similarity NPC473999
0.8222 Intermediate Similarity NPC122116
0.8222 Intermediate Similarity NPC215029
0.8222 Intermediate Similarity NPC54689
0.8222 Intermediate Similarity NPC220498
0.8222 Intermediate Similarity NPC76879
0.8222 Intermediate Similarity NPC476733
0.8202 Intermediate Similarity NPC58063
0.8202 Intermediate Similarity NPC317590
0.8202 Intermediate Similarity NPC472493
0.8193 Intermediate Similarity NPC73875
0.8191 Intermediate Similarity NPC122294
0.8191 Intermediate Similarity NPC320306
0.8182 Intermediate Similarity NPC471224
0.8182 Intermediate Similarity NPC474218
0.8172 Intermediate Similarity NPC45324
0.8172 Intermediate Similarity NPC162001
0.8172 Intermediate Similarity NPC184848
0.8172 Intermediate Similarity NPC472485
0.8172 Intermediate Similarity NPC37787
0.8172 Intermediate Similarity NPC180557
0.8172 Intermediate Similarity NPC271195
0.8172 Intermediate Similarity NPC473415
0.8172 Intermediate Similarity NPC48330
0.8172 Intermediate Similarity NPC473648
0.8172 Intermediate Similarity NPC30677
0.8172 Intermediate Similarity NPC469329
0.8172 Intermediate Similarity NPC127063
0.8172 Intermediate Similarity NPC222845
0.8172 Intermediate Similarity NPC69548
0.8163 Intermediate Similarity NPC149047
0.8163 Intermediate Similarity NPC171137
0.8163 Intermediate Similarity NPC152695
0.8163 Intermediate Similarity NPC97202
0.8163 Intermediate Similarity NPC202167
0.8163 Intermediate Similarity NPC85829
0.8163 Intermediate Similarity NPC302607
0.8163 Intermediate Similarity NPC319077
0.8163 Intermediate Similarity NPC49958
0.8163 Intermediate Similarity NPC260268
0.8163 Intermediate Similarity NPC50692
0.8163 Intermediate Similarity NPC214264
0.8163 Intermediate Similarity NPC150531
0.8163 Intermediate Similarity NPC296945
0.8163 Intermediate Similarity NPC476027
0.8163 Intermediate Similarity NPC48733
0.8163 Intermediate Similarity NPC166607
0.8161 Intermediate Similarity NPC472743
0.8161 Intermediate Similarity NPC278648
0.8161 Intermediate Similarity NPC132635
0.8161 Intermediate Similarity NPC475726
0.8161 Intermediate Similarity NPC472492
0.8161 Intermediate Similarity NPC476082
0.8161 Intermediate Similarity NPC207013
0.8152 Intermediate Similarity NPC474806
0.8152 Intermediate Similarity NPC470376
0.8152 Intermediate Similarity NPC275809
0.8152 Intermediate Similarity NPC170220
0.8152 Intermediate Similarity NPC243866
0.8152 Intermediate Similarity NPC472930
0.8152 Intermediate Similarity NPC109305
0.8152 Intermediate Similarity NPC107674
0.8152 Intermediate Similarity NPC141497

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC138756 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8488 Intermediate Similarity NPD4786 Approved
0.8427 Intermediate Similarity NPD5328 Approved
0.8295 Intermediate Similarity NPD3618 Phase 1
0.8256 Intermediate Similarity NPD3667 Approved
0.8242 Intermediate Similarity NPD6079 Approved
0.8152 Intermediate Similarity NPD4202 Approved
0.8 Intermediate Similarity NPD4755 Approved
0.7931 Intermediate Similarity NPD4692 Approved
0.7931 Intermediate Similarity NPD4139 Approved
0.7895 Intermediate Similarity NPD5222 Approved
0.7895 Intermediate Similarity NPD4697 Phase 3
0.7895 Intermediate Similarity NPD5221 Approved
0.7895 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD5279 Phase 3
0.7865 Intermediate Similarity NPD3133 Approved
0.7865 Intermediate Similarity NPD3666 Approved
0.7865 Intermediate Similarity NPD3665 Phase 1
0.7835 Intermediate Similarity NPD4700 Approved
0.7835 Intermediate Similarity NPD5286 Approved
0.7835 Intermediate Similarity NPD4696 Approved
0.7835 Intermediate Similarity NPD5285 Approved
0.7826 Intermediate Similarity NPD4753 Phase 2
0.7816 Intermediate Similarity NPD7525 Registered
0.7812 Intermediate Similarity NPD5173 Approved
0.7778 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7766 Intermediate Similarity NPD6399 Phase 3
0.7755 Intermediate Similarity NPD5223 Approved
0.7711 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD5211 Phase 2
0.7677 Intermediate Similarity NPD5225 Approved
0.7677 Intermediate Similarity NPD5226 Approved
0.7677 Intermediate Similarity NPD4633 Approved
0.7677 Intermediate Similarity NPD5224 Approved
0.7667 Intermediate Similarity NPD3668 Phase 3
0.766 Intermediate Similarity NPD7515 Phase 2
0.764 Intermediate Similarity NPD4223 Phase 3
0.764 Intermediate Similarity NPD4221 Approved
0.7624 Intermediate Similarity NPD5739 Approved
0.7624 Intermediate Similarity NPD7128 Approved
0.7624 Intermediate Similarity NPD6675 Approved
0.7624 Intermediate Similarity NPD6402 Approved
0.7614 Intermediate Similarity NPD4748 Discontinued
0.76 Intermediate Similarity NPD5175 Approved
0.76 Intermediate Similarity NPD5174 Approved
0.76 Intermediate Similarity NPD4754 Approved
0.7586 Intermediate Similarity NPD3617 Approved
0.7582 Intermediate Similarity NPD5329 Approved
0.7558 Intermediate Similarity NPD6117 Approved
0.7556 Intermediate Similarity NPD4788 Approved
0.7525 Intermediate Similarity NPD5141 Approved
0.75 Intermediate Similarity NPD5690 Phase 2
0.75 Intermediate Similarity NPD5280 Approved
0.75 Intermediate Similarity NPD4694 Approved
0.75 Intermediate Similarity NPD4634 Approved
0.7476 Intermediate Similarity NPD6881 Approved
0.7476 Intermediate Similarity NPD6899 Approved
0.7476 Intermediate Similarity NPD7320 Approved
0.7473 Intermediate Similarity NPD4197 Approved
0.7471 Intermediate Similarity NPD6116 Phase 1
0.747 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD4767 Approved
0.7451 Intermediate Similarity NPD4768 Approved
0.7449 Intermediate Similarity NPD6084 Phase 2
0.7449 Intermediate Similarity NPD6083 Phase 2
0.7442 Intermediate Similarity NPD7339 Approved
0.7442 Intermediate Similarity NPD6942 Approved
0.7423 Intermediate Similarity NPD5210 Approved
0.7423 Intermediate Similarity NPD4629 Approved
0.7423 Intermediate Similarity NPD5695 Phase 3
0.7404 Intermediate Similarity NPD6372 Approved
0.7404 Intermediate Similarity NPD6373 Approved
0.7386 Intermediate Similarity NPD6115 Approved
0.7386 Intermediate Similarity NPD6114 Approved
0.7386 Intermediate Similarity NPD6118 Approved
0.7386 Intermediate Similarity NPD6697 Approved
0.7379 Intermediate Similarity NPD5697 Approved
0.7379 Intermediate Similarity NPD5701 Approved
0.7358 Intermediate Similarity NPD8297 Approved
0.7349 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD5360 Phase 3
0.7333 Intermediate Similarity NPD7290 Approved
0.7333 Intermediate Similarity NPD7102 Approved
0.7333 Intermediate Similarity NPD6883 Approved
0.7326 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7748 Approved
0.7312 Intermediate Similarity NPD4688 Approved
0.7312 Intermediate Similarity NPD4689 Approved
0.7312 Intermediate Similarity NPD4138 Approved
0.7312 Intermediate Similarity NPD5205 Approved
0.7312 Intermediate Similarity NPD4690 Approved
0.7312 Intermediate Similarity NPD4693 Phase 3
0.7308 Intermediate Similarity NPD4729 Approved
0.7308 Intermediate Similarity NPD5128 Approved
0.7308 Intermediate Similarity NPD6011 Approved
0.7308 Intermediate Similarity NPD4730 Approved
0.7292 Intermediate Similarity NPD8034 Phase 2
0.7292 Intermediate Similarity NPD5284 Approved
0.7292 Intermediate Similarity NPD5281 Approved
0.7292 Intermediate Similarity NPD8035 Phase 2
0.729 Intermediate Similarity NPD4632 Approved
0.7264 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD6650 Approved
0.7264 Intermediate Similarity NPD6869 Approved
0.7264 Intermediate Similarity NPD6649 Approved
0.7264 Intermediate Similarity NPD6847 Approved
0.7264 Intermediate Similarity NPD8130 Phase 1
0.7264 Intermediate Similarity NPD6617 Approved
0.7262 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD7115 Discovery
0.7241 Intermediate Similarity NPD3703 Phase 2
0.7238 Intermediate Similarity NPD6013 Approved
0.7238 Intermediate Similarity NPD6014 Approved
0.7238 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD6012 Approved
0.7196 Intermediate Similarity NPD6882 Approved
0.7195 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD4245 Approved
0.7176 Intermediate Similarity NPD4789 Approved
0.7176 Intermediate Similarity NPD4244 Approved
0.717 Intermediate Similarity NPD5251 Approved
0.717 Intermediate Similarity NPD5250 Approved
0.717 Intermediate Similarity NPD5169 Approved
0.717 Intermediate Similarity NPD5249 Phase 3
0.717 Intermediate Similarity NPD5247 Approved
0.717 Intermediate Similarity NPD5248 Approved
0.717 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5135 Approved
0.7159 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD6933 Approved
0.7158 Intermediate Similarity NPD5737 Approved
0.7158 Intermediate Similarity NPD6672 Approved
0.7143 Intermediate Similarity NPD5168 Approved
0.7128 Intermediate Similarity NPD7521 Approved
0.7128 Intermediate Similarity NPD7334 Approved
0.7128 Intermediate Similarity NPD6684 Approved
0.7128 Intermediate Similarity NPD7146 Approved
0.7128 Intermediate Similarity NPD6409 Approved
0.7128 Intermediate Similarity NPD5330 Approved
0.7103 Intermediate Similarity NPD5215 Approved
0.7103 Intermediate Similarity NPD5127 Approved
0.7103 Intermediate Similarity NPD5216 Approved
0.7103 Intermediate Similarity NPD5217 Approved
0.71 Intermediate Similarity NPD7902 Approved
0.7075 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD3698 Phase 2
0.7048 Intermediate Similarity NPD6412 Phase 2
0.7041 Intermediate Similarity NPD5133 Approved
0.703 Intermediate Similarity NPD7638 Approved
0.703 Intermediate Similarity NPD5696 Approved
0.701 Intermediate Similarity NPD4096 Approved
0.6979 Remote Similarity NPD6903 Approved
0.6979 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7639 Approved
0.6961 Remote Similarity NPD7640 Approved
0.6947 Remote Similarity NPD6098 Approved
0.6939 Remote Similarity NPD6050 Approved
0.6937 Remote Similarity NPD6009 Approved
0.6932 Remote Similarity NPD5733 Approved
0.6932 Remote Similarity NPD6924 Approved
0.6932 Remote Similarity NPD6926 Approved
0.6923 Remote Similarity NPD7645 Phase 2
0.6923 Remote Similarity NPD4195 Approved
0.6909 Remote Similarity NPD5167 Approved
0.6907 Remote Similarity NPD6673 Approved
0.6907 Remote Similarity NPD6080 Approved
0.6907 Remote Similarity NPD6904 Approved
0.6903 Remote Similarity NPD6319 Approved
0.6903 Remote Similarity NPD6054 Approved
0.6903 Remote Similarity NPD6059 Approved
0.6897 Remote Similarity NPD4243 Approved
0.6897 Remote Similarity NPD4758 Discontinued
0.6875 Remote Similarity NPD6335 Approved
0.6848 Remote Similarity NPD4695 Discontinued
0.6847 Remote Similarity NPD6868 Approved
0.6847 Remote Similarity NPD6274 Approved
0.6837 Remote Similarity NPD5692 Phase 3
0.6827 Remote Similarity NPD7632 Discontinued
0.6814 Remote Similarity NPD7101 Approved
0.6814 Remote Similarity NPD7100 Approved
0.6813 Remote Similarity NPD3671 Phase 1
0.6813 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6813 Remote Similarity NPD5364 Discontinued
0.6804 Remote Similarity NPD4518 Approved
0.68 Remote Similarity NPD7901 Clinical (unspecified phase)
0.68 Remote Similarity NPD7900 Approved
0.6792 Remote Similarity NPD6008 Approved
0.6786 Remote Similarity NPD6317 Approved
0.6783 Remote Similarity NPD6370 Approved
0.6782 Remote Similarity NPD4747 Approved
0.6771 Remote Similarity NPD4623 Approved
0.6771 Remote Similarity NPD4519 Discontinued
0.6768 Remote Similarity NPD6411 Approved
0.6768 Remote Similarity NPD5694 Approved
0.6742 Remote Similarity NPD4784 Approved
0.6742 Remote Similarity NPD4785 Approved
0.6742 Remote Similarity NPD4687 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data